Recalls / Active ingredient / Sodium Glycerophosphate Anhydrous
Sodium Glycerophosphate Anhydrous
1 FDA drug recall involving the active ingredient “Sodium Glycerophosphate Anhydrous”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2015-04-28 | Class II | KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfit | Fresenius Kabi USA, LLC |